Cita APA (7a ed.)

M, S., JL, P., & J, A. (2021). Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press.

Cita Chicago Style (17a ed.)

M, Salas, Potenziano JL, y Acker J. Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press, 2021.

Cita MLA (8a ed.)

M, Salas, et al. Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging. Dove Medical Press, 2021.